Online citations, reference lists, and bibliographies.
← Back to Search

Albumin And Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded With Paclitaxel For Biomedical Applications

E. Vismara, Chiara Bongio, A. Coletti, Ravit Edelman, A. Serafini, Michele Mauri, R. Simonutti, S. Bertini, E. Urso, Y. Assaraf, Yoav D Livney
Published 2017 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Super paramagnetic iron oxide nanoparticles (SPION) were augmented by both hyaluronic acid (HA) and bovine serum albumin (BSA), each covalently conjugated to dopamine (DA) enabling their anchoring to the SPION. HA and BSA were found to simultaneously serve as stabilizing polymers of Fe3O4·DA-BSA/HA in water. Fe3O4·DA-BSA/HA efficiently entrapped and released the hydrophobic cytotoxic drug paclitaxel (PTX). The relative amount of HA and BSA modulates not only the total solubility but also the paramagnetic relaxation properties of the preparation. The entrapping of PTX did not influence the paramagnetic relaxation properties of Fe3O4·DA-BSA. Thus, by tuning the surface structure and loading, we can tune the theranostic properties of the system.
This paper references
10.1002/ADMA.200800756
Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging.
Yu-han Lee (2008)
10.1007/s11095-012-0672-1
Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma
Gal Journo-Gershfeld (2012)
10.2147/IJN.S63433
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
H. Unterweger (2014)
10.1089/TEN.TEB.2016.0437
Superparamagnetic Iron Oxide Nanoparticles in Musculoskeletal Biology
R. IyerShama (2016)
10.1016/j.drup.2011.01.003
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Alina Shapira (2011)
10.1021/acsnano.5b00640
Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy.
Q. Chen (2015)
10.1016/j.colsurfb.2015.02.003
Stable monodisperse nanomagnetic colloidal suspensions: An overview.
Donya Ramimoghadam (2015)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1016/j.addr.2013.08.006
Rationally designed nanovehicles to overcome cancer chemoresistance.
Yoav D Livney (2013)
10.1016/j.biomaterials.2009.09.030
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
K. Choi (2010)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1021/JA0464802
Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles.
C. Xu (2004)
150 and More Basic NMR Experiments: A Practical Course
S. Braun (1996)
10.1016/j.ijpharm.2017.01.011
Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel.
H. B. Ruttala (2017)
10.1111/j.1742-4658.2011.08071.x
Hyaluronan–CD44 interactions as potential targets for cancer therapy
S. Misra (2011)
10.1016/S1567-2719(05)16005-3
chapter 5 Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles
P. Tartaj (2006)
10.1248/cpb.c14-00423
Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
W. Lv (2015)
10.1155/2013/314091
Heparin and Carboxymethylchitosan Metal Nanoparticles: An Evaluation of Their Cytotoxicity
A. Bava (2013)
10.1039/B926720D
Thermoreversible gelation of poly(ethylene glycol)/poly(ester anhydride) triblock copolymer nanoparticles for injectable drug delivery systems
Yanqin Liang (2010)
10.1016/j.nano.2011.06.010
Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.
A. Skouras (2011)
Hierarchical self-assembly of PDMA-b-PS chains into granular nanoparticles: Genesis and fate. Macromol
A. Bianchi (2014)
10.1039/C1AY05131H
A method based on time domain nuclear magnetic resonance for the forensic differentiation of latex gloves
Michele Mauri (2011)
10.1002/wnan.36
Magnetic resonance relaxation properties of superparamagnetic particles.
Y. Gossuin (2009)
10.1002/CHIN.200547224
Synthesis, Properties, and Applications of Iron Nanoparticles
D. Huber (2005)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
10.2147/IJN.S68539
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
J. Zaloga (2014)
10.1039/C6RA26235J
Electrochemistry and surface-enhanced Raman spectroscopy of CTAB modulated interactions of magnetic nanoparticles with biomolecules
D. Joseph (2017)
10.1016/J.APSUSC.2006.05.023
Oleic acid coating on the monodisperse magnetite nanoparticles
L. Zhang (2006)
10.1021/cr300143v
Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology.
K. Sapsford (2013)
LOW MOLECULAR WEIGHT HEPARIN-VECTORIZED β-CYCLODEXTRIN NANOSTRUCTURES
S. Bertini (2008)
10.1016/j.colsurfb.2013.12.054
One-step fabrication of agent-loaded biodegradable microspheroids for drug delivery and imaging applications.
M. Heslinga (2014)
10.1038/nmeth.2089
NIH Image to ImageJ: 25 years of image analysis
C. Schneider (2012)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1039/C5RA27792B
A multifunctional nanoparticulate theranostic system with simultaneous chemotherapeutic, photothermal therapeutic, and MRI contrast capabilities
M. Zhang (2016)
10.1016/J.TET.2005.08.031
Amide bond formation and peptide coupling
C. Montalbetti (2005)
Spectrophotometric estimation of paclitaxel
Prashant Kesarwani (2011)
10.1016/0730-725X(84)90080-8
Gadolinium as a contrast agent for NMR.
J. Caillé (1983)
10.1016/J.NANTOD.2014.04.008
Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.
Sutapa Barua (2014)
10.1016/j.ejpb.2016.01.017
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
J. Zaloga (2016)
10.1016/J.COLSURFA.2016.07.086
Cloud point thermodynamics of paclitaxel-loaded microemulsion in the presence of glucose and NaCl
W. Wang (2016)
10.3978/j.issn.2223-4292.2011.08.03
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
10.3390/ijms140713463
Non-Covalent Synthesis of Metal Oxide Nanoparticle–Heparin Hybrid Systems: A New Approach to Bioactive Nanoparticles
E. Vismara (2013)
10.1039/C6RA11260A
Hyaluronic acid anchored paclitaxel nanocrystals improves chemotherapeutic efficacy and inhibits lung metastasis in tumor-bearing rat model
S. Sharma (2016)
10.1002/marc.201400414
Hierarchical self-assembly of PDMA-b-PS chains into granular nanoparticles: genesis and fate.
A. Bianchi (2014)
10.1016/J.JMMM.2006.03.049
Preparation and characterization of hydrophobic superparamagnetic magnetite gel
Xianqiao Liu (2006)
10.1016/j.actbio.2015.01.006
Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.
H. Li (2015)
10.1021/LA020918Z
Siderophore-mediated covalent bonding to metal (oxide) surfaces during biofilm initiation by Pseudomonas aeruginosa bacteria
Michael J. Mcwhirter (2003)
10.1021/acsnano.6b06040
Diverse Applications of Nanomedicine
B. Pelaz (2017)
10.1002/CHIN.200837219
Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles.
P. Tartaj (2008)
10.1073/pnas.1620145114
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
H. Wei (2017)
10.1016/j.jconrel.2014.03.057
EPR: Evidence and fallacy.
Joseph W. Nichols (2014)
10.1158/0008-5472.CAN-15-1576
Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
T. Tanei (2016)
10.2217/17435889.2.1.23
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
A. Gupta (2007)
10.1016/j.nano.2015.10.019
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Zahra Bakhtiary (2016)
10.2147/IJN.S132369
Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake
Johanna M Poller (2017)
10.1021/la404757q
Simple ligand exchange reactions enabling excellent dispersibility and stability of magnetic nanoparticles in polar organic, aromatic, and protic solvents.
X. Wang (2014)
10.1016/j.biomaterials.2010.01.010
PET/NIRF/MRI triple functional iron oxide nanoparticles.
J. Xie (2010)
10.1021/am301301f
Ultrasound-triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imaging.
Bingbo Zhang (2012)
10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)



This paper is referenced by
10.3390/APP9091801
Time Domain NMR in Polymer Science: From the Laboratory to the Industry
Denise Besghini (2019)
10.1002/adtp.201900081
Paclitaxel‐Loaded Iron Oxide Nanoparticles for Targeted Breast Cancer Therapy
Mike Jeon (2019)
10.1016/j.bbagen.2019.02.012
A health concern regarding the protein corona, aggregation and disaggregation
M. Falahati (2019)
10.2147/IJN.S156528
Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety
H. Unterweger (2018)
10.3390/molecules23020293
Looking Forward to the Future of Heparin: New Sources, Developments and Applications
G. Torri (2018)
10.2147/IJN.S184723
A review of small molecules and drug delivery applications using gold and iron nanoparticles
Hossein Jahangirian (2019)
10.1016/j.drup.2019.100673
Emerging roles of F-box proteins in cancer drug resistance.
Linzhi Yan (2019)
10.1016/j.addr.2019.01.005
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Seyed Mohammadali Dadfar (2019)
10.3390/molecules23112982
Adsorption of Cu(II) and Zn(II) Ions from Aqueous Solution by Gel/PVA-Modified Super-Paramagnetic Iron Oxide Nanoparticles
Anudari Dolgormaa (2018)
10.1016/J.JPCS.2019.06.016
Biocompatible and high-magnetically responsive iron oxide nanoparticles for protein loading
A. Gaspar (2019)
10.1016/j.carbpol.2018.12.104
LC-MS/MS study of in vivo fate of hyaluronan polymeric micelles carrying doxorubicin.
M. Šimek (2019)
10.1002/POLA.29387
The effect of cationic groups on the stability of 19 F MRI contrast agents in nanoparticles
A. Piloni (2019)
10.3390/biomimetics5020027
Metal Oxide Nanoparticles as Biomedical Materials
Maria P Nikolova (2020)
10.1016/j.abb.2020.108592
Understanding the influence of experimental factors on bio-interactions of nanoparticles: Towards improving correlation between in vitro and in vivo studies
Pavithra Natarajan (2020)
Semantic Scholar Logo Some data provided by SemanticScholar